-
Nirmatrelvir
API’s Name Indication Innovator Patent Expiry Date(The U.S) Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor And SARS-Cov-2 Mpro Inhibitor -
Niraparib 1038915-60-4
API’s Name Indication Innovator Patent Expiry Date(The U.S) Niraparib 1038915-60-4 Ovarian/Fallopian,tube/primary peritoneal cancer Tesaro Jan.8, 2028